Main Article Content
Abstract
The Patient G., 16 years old with polymorphic nonspecific complaints, since 2011.
Objective – to analyse rare clinical case of the manifestation of acute intermittent porphyria (AIP) of sixteen-year-old girl, to trace the sequence of increase of clinical symptoms.
Methods. To verify the diagnosis the method of determination of porphobilinogen (PBG) and δ-aminolevulinic acid (ALA) in urine was used. It is based on their separation by adsorption on columns with ion-exchange resin (ion-exchange column chromatography) with subsequent use of the Ehrlich reagent and measurement of results on a spectrophotometer in the wavelength range of 500-600 nm.
Results. Acute intermittent porphyria was diagnosed confirmed by laboratory.
Conclusions. At first patients get to the non-core departments, depending on the prevalence of main symptoms, many laboratories, even in large interregional clinics, do not have an opportunity the technique and special reagents of Ehrlich to determine porphyrins in the urine, the only pathogenetic method of treatment are hemе`s drugs, recently licensed in Russia.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Diagnosis and treatment of acute porphyria: Federal clinical guidelines. 2013. URL: https://www.volgmed.ru/uploads/files/2014-11/34211-federalnye_klinicheskie_rekomendacii_po_diagnostike_i_lecheniyu_ostryh_porfirij_2013_http_npngo_ru.pdf Russian (Диагностика и лечение острых порфирий: федеральные клинические рекомендации, 2013 г.)
Senderova OM, Glinskaya EV, Glinsky AA, Gorokhova LA, Vorobyov AI, Kravchenko SK. et al. Clinical experience in the diagnosis and treatment of acute porphyria. Siberian medical journal. 2009; (2): 108-109. Russian (Сендерова О.М., Глинская Е.В., Глинский А.А., Горохова Л.А., Воробьёв А.И., Кравченко С.К. и др. Клинический опыт диагностики и лечения острой перемежающейся порфирии //Сибирский медицинский журнал. 2009. № 2. С. 108-109
Diagnosis and treatment of acute porphyria: national clinical guidelines. 2018. URL: https://npngo.ru/uploads/media_document/279/044fc924-3591-4898-b1df-0e11110bdb93.pdf. Russian (Диагностика и лечение острых порфирий: национальные клинические рекомендации, 2018 г.)
Siegesmund M, van Tuyll van Serooskerken AM, Poblete-Gutiérrez P, Frank J. The acute hepatic porphyrias: current status and future challenges. Best Pract Res Clin Gastroenterol. 2010; 24(5): 593-605. DOI: 10.1016/j.bpg.2010.08.010
Herrick AL., McColl KE., Acute intermittent porphyria //Best Pract Res Clin Gastroenterol. 2005; 19(2): 235-249
Zagidullina KL, Popova NA, Astashina EE. Difficulties in the diagnosis of acute intermittent porphyria in clinical practice. Kazan medical journal. 2016; 97(6): 975-977. Russian (Загидуллина К.Л., Попова Н.А., Асташина Е.Е. Сложности диагностики острой перемежающейся порфирии в клинической практике //Казанский медицинский журнал. 2016. Т. 97, № 6. С. 975-977)
Marsden JT, Rees DC. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria //J Clin Pathol. 2014; 67(1): 60-65